These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 34659602)

  • 1. Post COVID-19 vaccination neuromyelitis optica spectrum disorder: Case report & MRI findings.
    Badrawi N; Kumar N; Albastaki U
    Radiol Case Rep; 2021 Dec; 16(12):3864-3867. PubMed ID: 34659602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
    Anamnart C; Tisavipat N; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
    Mult Scler Relat Disord; 2022 Feb; 58():103414. PubMed ID: 35216789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
    Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
    Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
    BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Positive Neuromyelitis Optica Spectrum Disorder After Second COVID-19 Vaccination: a Case Report.
    Kuntz S; Saab G; Schneider R
    SN Compr Clin Med; 2022; 4(1):130. PubMed ID: 35761845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.
    Chen S; Fan XR; He S; Zhang JW; Li SJ
    Neurol Sci; 2021 Sep; 42(9):3537-3539. PubMed ID: 34189662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seronegative Neuromyelitis Optica Spectrum Disorder following Exposure to Hepatitis B Vaccination.
    Heekin R; Gandhy C; Robertson D
    Case Rep Neurol; 2015; 7(1):78-83. PubMed ID: 25969683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine.
    Fujikawa P; Shah FA; Braford M; Patel K; Madey J
    Cureus; 2021 Sep; 13(9):e17961. PubMed ID: 34660149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic neuromyelitis after vaccination against SARS-CoV-2.
    Hernandez-Vega M; Orozco-Narvaez A; Reyes-Vaca JG; Rodriguez-Leyva I
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36574993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review.
    Harel T; Gorman EF; Wallin MT
    Front Neurol; 2023; 14():1099758. PubMed ID: 37426444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
    Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
    Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
    Mealy MA; Cook LJ; Pache F; Velez DL; Borisow N; Becker D; Arango JAJ; Paul F; Levy M
    Mult Scler Relat Disord; 2018 Jul; 23():78-82. PubMed ID: 29783157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder with recurrent short partial transverse myelitis and favorable prognosis: Two new cases.
    Zhang J; Liu F; Wang Y; Yang Y; Huang Y; Zhao H; Bi Y; Shi T; Guo S; Wang M
    Mult Scler; 2017 Dec; 23(14):1950-1954. PubMed ID: 28580873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of neuromyelitis optica spectrum disorder following seasonal influenza vaccination.
    Cho JH; Park Y; Woo N
    Mult Scler Relat Disord; 2019 May; 30():110-113. PubMed ID: 30769255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis.
    Hernández ZM; Cohen BA; Derwenskus J
    Mult Scler Relat Disord; 2012 Oct; 1(4):202-3. PubMed ID: 25877268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
    Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
    Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.